# An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia

> **NCT06799611** · PHASE2 · RECRUITING · sponsor: **Institute of Hematology & Blood Diseases Hospital, China** · enrollment: 20 (estimated)

## Conditions studied

- Immune Thrombocytopenia (ITP)
- Treatment

## Interventions

- **DRUG:** CM336 Injection

## Key facts

- **NCT ID:** NCT06799611
- **Lead sponsor:** Institute of Hematology & Blood Diseases Hospital, China
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-03
- **Primary completion:** 2026-01-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06799611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06799611, "An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06799611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*